Extracorporeal Membrane Oxygenation Support in Severe COVID-19.

ABSTRACT:

Background

Coronavirus disease 2019 (COVID-19) remains a worldwide pandemic with a high mortality rate among patients requiring mechanical ventilation. The limited data that exist regarding the utility of extracorporeal membrane oxygenation (ECMO) in these critically ill patients show poor overall outcomes. This report describes our institutional practice regarding the application and management of ECMO support for patients with COVID-19 and reports promising early outcomes.

Methods

All critically ill patients with confirmed COVID-19 evaluated for ECMO support from March 10, 2020, to April 24, 2020, were retrospectively reviewed. Patients were evaluated for ECMO support based on a partial pressure of arterial oxygen/fraction of inspired oxygen ratio of less than 150 mm Hg or

SUBMITTER: Kon ZN 

PROVIDER: S-EPMC7366119 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature